NEW YORK, March 31, 2011 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:

Molecular Diagnostics in Infectious Disease Testing

http://www.reportlinker.com/p0368860/Molecular-Diagnostics-in-Infectious-Disease-Testing.html

This TriMark Publications report describes the specific segment
of the in vitro diagnostics market known as molecular diagnostics
testing for infectious disease. In the current medical diagnostics
market, molecular diagnostics in infectious disease testing offers
one of the most promising areas for growth and innovation. The
confluence of breakthroughs in genomics and proteomics–along with
the development of microarray devices to measure analytes in the
blood–has led to this revolutionary market development.
Specifically, molecular diagnostics offers the power of advanced
analytical techniques to diagnose infectious diseases. Whereas
before, the detection of many infectious agents was slow and
expensive due to reliance upon culturing methods, researchers are
now at the cusp of overcoming such limitations via the use of
nucleic acid-mediated molecular diagnostics testing. The purpose of
this report is to describe the emerging field of molecular
diagnostics in infectious disease testing. The infectious disease
space is the most dominant and profitable sector of molecular
diagnostics. Topics covered in this study include: 1) the existing
and emerging technologies in the field, 2) the U.S. and global
market size for molecular diagnostic products and 3) the profiles
of companies that are focusing on the molecular diagnostic sector.
The research examines drivers and restraints for sales

‘/>”/>

SOURCE